EX-23.1 5 antx-ex23_1.htm EX-23.1 EX-23.1

 

 

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-263917) of AN2 Therapeutics, Inc. of our report dated March 29, 2024 relating to the financial statements, which appears in this Form 10-K.

 

 

/s/ PricewaterhouseCoopers LLP


San Jose, California
March 29, 2024

1